Picking through the rubble of SVB’s collapse, what’s next for Medtech, VCs and startups?

A week after the SVB Wall’s fall, we talk with medical device leaders about how they managed the run on Silicon Valley Bank, which filed for Chapter 11 bankruptcy procedure on the morning of the day this episode was published. Pristine Surgical CEO Bryan Lord recounts the steps his management team took after the news broke Thursday night. He also walks us through the 10-point plan that he posted on LinkedIn, including commentary on how members of the industry can support each other. You can read his post here. https://www.linkedin.com/posts/bryanlord_one-ceos-playbook-for-svb-depositors-1-activity-7040425947308650496-FsEc?utm_source=share&utm_medium=member_desktop Joe Mullings, CEO of the Mullings Group, says the venture capital and medtech industry need to take a long look in the mirror given their response to SVB’s cloudy financial picture. Now, the Medtech industry is facing uncertainty over the next 90 days as things sort out. Medtech Innovator CEO Paul Grand walks through this week’s Newmarker’s Newsmakers with us including Perkin Elmer, Fire1, Medtronic, and, of course, Silicon Valley Bank. Paul shares his reaction to the SVB last week, the current economic climate, and what challenges Medtech may be facing in the future. Thanks for listening to the DeviceTalks Weekly Podcast. You can subscribe to the DeviceTalks Podcast Network on any major podcast application.